 Arleta Rewers
Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Ketoacidosis | 38 | 2024 | 202 | 7.760 |
Why?
| | Diabetes Mellitus, Type 1 | 26 | 2024 | 3710 | 1.660 |
Why?
| | Fluid Therapy | 11 | 2023 | 147 | 1.440 |
Why?
| | Hypoglycemia | 7 | 2020 | 443 | 0.790 |
Why?
| | Diabetes Mellitus | 7 | 2023 | 1036 | 0.750 |
Why?
| | Acidosis | 1 | 2021 | 101 | 0.660 |
Why?
| | Child | 43 | 2024 | 21999 | 0.610 |
Why?
| | Insulin | 8 | 2018 | 2406 | 0.550 |
Why?
| | Adolescent | 33 | 2024 | 21499 | 0.500 |
Why?
| | Hyperglycemic Hyperosmolar Nonketotic Coma | 3 | 2022 | 7 | 0.450 |
Why?
| | Blood Glucose | 6 | 2023 | 2182 | 0.430 |
Why?
| | Child, Preschool | 21 | 2024 | 11080 | 0.410 |
Why?
| | Colorado | 8 | 2024 | 4527 | 0.360 |
Why?
| | Infant | 17 | 2024 | 9451 | 0.350 |
Why?
| | Hospitalization | 3 | 2016 | 2214 | 0.340 |
Why?
| | Sodium | 2 | 2021 | 217 | 0.330 |
Why?
| | Hypoglycemic Agents | 5 | 2022 | 1283 | 0.330 |
Why?
| | Diabetic Nephropathies | 2 | 2022 | 294 | 0.290 |
Why?
| | Hyperglycemia | 3 | 2024 | 347 | 0.290 |
Why?
| | Quality Improvement | 1 | 2016 | 1172 | 0.280 |
Why?
| | Humans | 46 | 2024 | 137294 | 0.270 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2006 | 17 | 0.270 |
Why?
| | Bicarbonates | 2 | 2017 | 44 | 0.260 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2017 | 564 | 0.240 |
Why?
| | Brain Injuries | 2 | 2022 | 493 | 0.230 |
Why?
| | Glasgow Coma Scale | 3 | 2021 | 182 | 0.230 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 163 | 0.230 |
Why?
| | Socioeconomic Factors | 4 | 2017 | 1286 | 0.230 |
Why?
| | Emergency Service, Hospital | 5 | 2023 | 2054 | 0.230 |
Why?
| | Severity of Illness Index | 8 | 2021 | 2836 | 0.220 |
Why?
| | Male | 27 | 2024 | 67560 | 0.220 |
Why?
| | Multiple Trauma | 1 | 2005 | 101 | 0.220 |
Why?
| | Femoral Fractures | 1 | 2005 | 80 | 0.220 |
Why?
| | Prevalence | 5 | 2024 | 2715 | 0.220 |
Why?
| | Female | 27 | 2024 | 73052 | 0.210 |
Why?
| | Acute Kidney Injury | 2 | 2021 | 811 | 0.200 |
Why?
| | Electrolytes | 2 | 2021 | 58 | 0.200 |
Why?
| | Hypertension | 2 | 2023 | 1285 | 0.190 |
Why?
| | White Matter | 1 | 2023 | 145 | 0.180 |
Why?
| | Neurocognitive Disorders | 1 | 2020 | 26 | 0.180 |
Why?
| | Kidney Tubules | 1 | 2021 | 117 | 0.170 |
Why?
| | Risk Factors | 9 | 2022 | 10368 | 0.170 |
Why?
| | Communicable Disease Control | 1 | 2021 | 82 | 0.170 |
Why?
| | Brain Edema | 3 | 2018 | 61 | 0.170 |
Why?
| | Emergencies | 1 | 2020 | 165 | 0.150 |
Why?
| | Rehydration Solutions | 1 | 2018 | 8 | 0.150 |
Why?
| | Incidence | 4 | 2015 | 2808 | 0.150 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 385 | 0.140 |
Why?
| | Logistic Models | 3 | 2015 | 2071 | 0.140 |
Why?
| | Endocrinology | 1 | 2018 | 79 | 0.140 |
Why?
| | Pediatrics | 3 | 2018 | 1113 | 0.130 |
Why?
| | Pediatric Obesity | 1 | 2023 | 590 | 0.130 |
Why?
| | Cognition | 2 | 2023 | 1169 | 0.130 |
Why?
| | Pandemics | 2 | 2022 | 1623 | 0.120 |
Why?
| | Length of Stay | 2 | 2016 | 1218 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 160 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2016 | 10800 | 0.120 |
Why?
| | Matrix Metalloproteinases | 1 | 2016 | 94 | 0.120 |
Why?
| | Prospective Studies | 5 | 2021 | 7595 | 0.110 |
Why?
| | Cohort Studies | 5 | 2023 | 5726 | 0.100 |
Why?
| | Insulin Infusion Systems | 1 | 2017 | 394 | 0.100 |
Why?
| | Blood Pressure | 1 | 2020 | 1776 | 0.100 |
Why?
| | Infant, Newborn | 4 | 2019 | 6054 | 0.100 |
Why?
| | Hospitals, Pediatric | 1 | 2016 | 533 | 0.100 |
Why?
| | United States | 5 | 2020 | 14742 | 0.100 |
Why?
| | Adolescent Development | 1 | 2013 | 87 | 0.100 |
Why?
| | Follow-Up Studies | 2 | 2018 | 5125 | 0.090 |
Why?
| | Prognosis | 3 | 2020 | 4026 | 0.090 |
Why?
| | Combined Modality Therapy | 2 | 2014 | 1237 | 0.090 |
Why?
| | Emergency Medical Services | 2 | 2018 | 548 | 0.090 |
Why?
| | Blood Urea Nitrogen | 3 | 2022 | 54 | 0.080 |
Why?
| | Infusions, Intravenous | 2 | 2023 | 412 | 0.080 |
Why?
| | Precision Medicine | 1 | 2014 | 428 | 0.080 |
Why?
| | Patient Transfer | 1 | 2012 | 168 | 0.080 |
Why?
| | Triage | 1 | 2012 | 220 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 740 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2850 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2014 | 2516 | 0.080 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 99 | 0.080 |
Why?
| | Sodium Chloride | 2 | 2021 | 142 | 0.080 |
Why?
| | Biomarkers | 2 | 2021 | 4164 | 0.080 |
Why?
| | Amylases | 1 | 2008 | 17 | 0.070 |
Why?
| | Glomerular Filtration Rate | 2 | 2023 | 745 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1577 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 471 | 0.070 |
Why?
| | Lipase | 1 | 2008 | 69 | 0.070 |
Why?
| | Monitoring, Physiologic | 1 | 2010 | 268 | 0.070 |
Why?
| | Consensus | 2 | 2022 | 680 | 0.070 |
Why?
| | Dehydration | 2 | 2023 | 52 | 0.070 |
Why?
| | Electrochemistry | 1 | 2006 | 79 | 0.070 |
Why?
| | Drug Administration Schedule | 2 | 2018 | 786 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2023 | 15639 | 0.060 |
Why?
| | Insurance, Health | 1 | 2008 | 280 | 0.060 |
Why?
| | Educational Status | 1 | 2008 | 484 | 0.060 |
Why?
| | Small-Area Analysis | 1 | 2005 | 7 | 0.060 |
Why?
| | Abbreviated Injury Scale | 1 | 2005 | 22 | 0.060 |
Why?
| | Wounds and Injuries | 1 | 2012 | 756 | 0.060 |
Why?
| | Models, Biological | 1 | 2012 | 1773 | 0.060 |
Why?
| | Survival Rate | 1 | 2010 | 1970 | 0.060 |
Why?
| | Medically Uninsured | 1 | 2005 | 129 | 0.060 |
Why?
| | International Classification of Diseases | 1 | 2005 | 132 | 0.060 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1484 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2023 | 82 | 0.050 |
Why?
| | Creatine | 1 | 2023 | 60 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2008 | 1521 | 0.050 |
Why?
| | Emergency Medicine | 1 | 2005 | 225 | 0.050 |
Why?
| | Threonine | 1 | 2022 | 46 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 308 | 0.050 |
Why?
| | Histidine | 1 | 2022 | 64 | 0.050 |
Why?
| | Choline | 1 | 2023 | 131 | 0.050 |
Why?
| | Electrocardiography | 1 | 2005 | 630 | 0.050 |
Why?
| | Heart Diseases | 1 | 2005 | 359 | 0.050 |
Why?
| | Leucine | 1 | 2022 | 111 | 0.050 |
Why?
| | Glycopeptides | 1 | 2021 | 43 | 0.040 |
Why?
| | Intelligence Tests | 1 | 2020 | 59 | 0.040 |
Why?
| | Tryptophan | 1 | 2022 | 183 | 0.040 |
Why?
| | Chlorides | 1 | 2021 | 136 | 0.040 |
Why?
| | Mental Status and Dementia Tests | 1 | 2020 | 26 | 0.040 |
Why?
| | Registries | 2 | 2022 | 2016 | 0.040 |
Why?
| | Uric Acid | 1 | 2021 | 163 | 0.040 |
Why?
| | Risk Assessment | 1 | 2010 | 3439 | 0.040 |
Why?
| | Creatinine | 1 | 2022 | 499 | 0.040 |
Why?
| | Parents | 1 | 2008 | 1357 | 0.040 |
Why?
| | Acute Disease | 1 | 2002 | 1009 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 557 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3568 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2023 | 1045 | 0.040 |
Why?
| | Memory | 1 | 2020 | 255 | 0.040 |
Why?
| | Amino Acids | 1 | 2022 | 501 | 0.040 |
Why?
| | International Cooperation | 1 | 2018 | 199 | 0.040 |
Why?
| | Pilot Projects | 1 | 2023 | 1700 | 0.040 |
Why?
| | Patient Care Planning | 1 | 2018 | 158 | 0.030 |
Why?
| | Clinical Competence | 1 | 2005 | 1100 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1028 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1464 | 0.030 |
Why?
| | Sex Factors | 1 | 2002 | 2073 | 0.030 |
Why?
| | Self Efficacy | 1 | 2018 | 395 | 0.030 |
Why?
| | International Agencies | 1 | 2014 | 35 | 0.030 |
Why?
| | Age Factors | 1 | 2002 | 3297 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2014 | 51 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 822 | 0.030 |
Why?
| | Adolescent Medicine | 1 | 2014 | 36 | 0.030 |
Why?
| | Mental Disorders | 1 | 2002 | 1077 | 0.030 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2018 | 638 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2014 | 219 | 0.020 |
Why?
| | Child Mortality | 1 | 2012 | 16 | 0.020 |
Why?
| | Syndrome | 1 | 2012 | 357 | 0.020 |
Why?
| | Adult | 3 | 2013 | 37724 | 0.020 |
Why?
| | Brain | 1 | 2023 | 2675 | 0.020 |
Why?
| | Exercise | 2 | 2014 | 2045 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2012 | 524 | 0.020 |
Why?
| | Risk | 1 | 2013 | 908 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 2014 | 468 | 0.020 |
Why?
| | Trauma Centers | 1 | 2012 | 422 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1302 | 0.020 |
Why?
| | Speech Disorders | 1 | 2009 | 34 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 109 | 0.020 |
Why?
| | Hyperventilation | 1 | 2008 | 10 | 0.020 |
Why?
| | Mood Disorders | 1 | 2009 | 129 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2008 | 171 | 0.020 |
Why?
| | Vision Disorders | 1 | 2009 | 141 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3546 | 0.020 |
Why?
| | Hospitals, University | 1 | 2008 | 183 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6818 | 0.020 |
Why?
| | Magnesium | 1 | 2008 | 158 | 0.020 |
Why?
| | Respiration | 1 | 2008 | 198 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 183 | 0.020 |
Why?
| | Awareness | 1 | 2008 | 105 | 0.020 |
Why?
| | Young Adult | 2 | 2014 | 13163 | 0.020 |
Why?
| | Eating | 1 | 2009 | 379 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 519 | 0.020 |
Why?
| | Cerebral Ventricles | 1 | 2006 | 52 | 0.020 |
Why?
| | Triglycerides | 1 | 2008 | 524 | 0.020 |
Why?
| | Parent-Child Relations | 1 | 2008 | 271 | 0.010 |
Why?
| | Headache | 1 | 2006 | 151 | 0.010 |
Why?
| | Cardiology | 1 | 2005 | 278 | 0.010 |
Why?
| | Medicaid | 1 | 2005 | 434 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1946 | 0.010 |
Why?
|
|
Rewers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|